Edition:
United States

Insider Trading: Orexigen Therapeutics Inc (OREX.OQ)

OREX.OQ on NASDAQ Stock Exchange Global Select Market

2.37USD
21 Aug 2017
Change (% chg)

$-0.05 (-2.07%)
Prev Close
$2.42
Open
$2.44
Day's High
$2.44
Day's Low
$2.31
Volume
4,143
Avg. Vol
24,234
52-wk High
$5.69
52-wk Low
$1.66

DP VII ASSOCIATES L P

Institutional Holders

% Shares Owned: 48.45%
# of Holders: 66
Total Shares Held: 7,476,678
3 Mo. Net Change: -645,110
# New Positions: 7
# Closed Positions: 7
# Increased Positions: 16
# Reduced Positions: 24
# Net Buyers: -8

Officers & Directors

Name Age Since Current Position

Patrick Mahaffy

54 2016 Independent Chairman of the Board

Michael Narachi

57 2016 President, Chief Executive Officer, Director

Jason Keyes

46 2016 Chief Financial Officer, Senior Vice President

Thomas Cannell

55 2016 Chief Operating Officer, Executive Vice President, President - Global Commercial Products

Thomas Lynch

50 2015 Executive Vice President, General Counsel, Secretary

Peter Flynn

43 2016 Senior Vice President, Head - Development, Regulatory Affairs and Safety

Louis Bock

52 2005 Independent Director

Brian Dovey

75 2004 Independent Director

David Endicott

52 2012 Independent Director

Peter Honig

60 2010 Independent Director

Debora Jorn

59 2016 Independent Director

Lota Zoth

57 2012 Independent Director